Case Details
- Citation: [2022] SGCA 39
- Title: A Steven s/o Paul Raj v Public Prosecutor
- Court: Court of Appeal of the Republic of Singapore
- Date of Decision: 11 May 2022
- Criminal Appeal No: Criminal Appeal No 24 of 2021
- Judges: Andrew Phang Boon Leong JCA, Judith Prakash JCA and Steven Chong JCA
- Appellant: A Steven s/o Paul Raj
- Respondent: Public Prosecutor
- Legal Area: Criminal Law — Statutory offences
- Statutes Referenced: Criminal Procedure Code (Cap 68, 2012 Rev Ed); Misuse of Drugs Act (Cap 185, 2008 Rev Ed)
- Key Provisions: Misuse of Drugs Act ss 5(1)(a), 5(2), 17(c), 33(1), Second Schedule; Criminal Procedure Code s 22
- Charge: Trafficking in a controlled drug under s 5(1)(a) read with s 5(2) of the Misuse of Drugs Act
- Controlled Drugs / Quantity: Two packets containing not less than 901.5g of granular/powdery substance, containing not less than 35.85g of diamorphine
- Defence: Consumption defence (personal consumption / occasional reciprocal sharing)
- Sentence at Trial: Mandatory death sentence under s 33(1) read with the Second Schedule (as the alternative sentencing regime under ss 33B(1) and 33B(2) did not apply)
- Outcome on Appeal: Appeal dismissed; conviction and sentence upheld
- Judgment Length: 26 pages, 7,585 words
- Related Authorities Cited: [1995] SGHC 120; [2021] SGHC 218; [2022] SGCA 39
Summary
In A Steven s/o Paul Raj v Public Prosecutor ([2022] SGCA 39), the Court of Appeal upheld the appellant’s conviction for trafficking in diamorphine under the Misuse of Drugs Act (“MDA”). The appellant did not dispute that he possessed the relevant drugs or that he knew they were diamorphine. The sole issue on appeal was whether he could rebut the statutory presumption of trafficking by establishing, on a balance of probabilities, that the entire quantity was meant for his own consumption (or, in his account, occasional reciprocal sharing with friends), rather than for trafficking to others.
The Court of Appeal agreed with the trial judge that the appellant failed to discharge his burden. Central to the court’s reasoning were (i) the lack of credible and consistent evidence supporting the claimed rate of consumption, (ii) the implausibility of the appellant’s explanation for possessing such a large quantity, and (iii) the presence of drug trafficking paraphernalia—particularly multiple zip lock bags and weighing scales—which undermined the consumption narrative. The appeal was therefore dismissed and the mandatory death sentence remained in place.
What Were the Facts of This Case?
The appellant, a 57-year-old Singapore citizen and an odd-job labourer at the material time, was arrested by Central Narcotics Bureau (“CNB”) officers on 24 October 2017 at about 5.43am. Earlier that morning, at approximately 5.40am, he was stopped at a traffic light junction along Serangoon Road while riding a motorised bicycle. The drugs were found in the course of searches following his arrest.
On 23 October 2017, the appellant had ordered two “batu” of “panas” (a street name for diamorphine) from a Malaysian supplier known as “Abang”. The precise details of the conversation between the appellant and “Abang” were disputed. However, it was not disputed that the appellant received the drugs on 24 October 2017 at Boon Keng MRT station and that the seized drugs corresponded to the order.
CNB recovered multiple controlled substances and drug-related items. The key charge related to two packets of granular/powdery substances found in the basket of the bicycle, secured with a combination padlock. These packets contained a total of 901.5g of granular/powdery substance, which analysis showed contained not less than 35.85g of diamorphine. In addition to the relevant drugs, CNB found another zip lock bag containing not less than 0.39g of diamorphine in the appellant’s flat (beneath the kitchen sink). CNB also found three packets of crystalline substance containing methamphetamine in the appellant’s trouser pockets and/or in the bicycle basket.
Beyond the drugs themselves, CNB found paraphernalia beneath the kitchen sink, including a yellow cut straw stained with diamorphine, an assortment of empty zip lock bags, stained aluminium foil and an improvised smoking utensil, stained spoons and lighters, and four digital weighing scales. These items were significant because they are commonly associated with drug preparation and distribution. The appellant also had bank account funds and transaction history: as at 31 October 2017, he had $9,892.32 in his DBS account, with total inflows of $63,750.67 and outflows of $67,524.24 between January 2017 and October 2017. The trial judge treated the financial evidence as neutral and equivocal rather than determinative.
What Were the Key Legal Issues?
The principal legal issue was whether the appellant could rebut the statutory presumption of trafficking under s 17(c) of the MDA. Because the diamorphine exceeded the statutory threshold of 2g, the presumption applied. The appellant’s burden was therefore to establish, on a balance of probabilities, that he possessed the relevant drugs not for trafficking but for his own consumption (or, as he put it, occasional reciprocal arrangements with friends).
A secondary issue concerned the credibility and sufficiency of the appellant’s evidence in support of the consumption defence. In particular, the court had to assess whether the appellant’s claimed rate of consumption was consistent with the medical evidence and whether his explanations for the quantity of drugs and the presence of paraphernalia were plausible. The court also had to consider whether any admissions or statements given by the appellant were inconsistent with the consumption narrative.
How Did the Court Analyse the Issues?
The Court of Appeal began by reaffirming the structure of the MDA trafficking framework. Where the accused is found in possession of a controlled drug and the quantity exceeds the threshold, the presumption of trafficking under s 17(c) arises. The accused must then rebut the presumption by proving, on a balance of probabilities, that the drugs were intended for personal consumption rather than trafficking. Importantly, the court emphasised that, in this case, the appellant’s defence required him to establish that the entire amount of the relevant drugs was meant for consumption. This was contrasted with cases where an accused might credibly show that only part of the drugs was for consumption and the remainder was for trafficking, potentially affecting whether the capital threshold for trafficking was met.
On the consumption defence, the court scrutinised the appellant’s claimed consumption rate and the consistency of his account. The trial judge had found that the appellant’s evidence was not sufficiently consistent or cogent to establish his claimed rate of consumption. The Court of Appeal agreed. The appellant’s account was contradicted by evidence from doctors who examined him, and the appellant’s explanations for discrepancies were not convincing. The court also considered whether the appellant’s mental state—purported distress, withdrawal symptoms, and any depressive disorder—could have affected his ability to communicate accurately with the doctors or to give statements. The trial judge had found that it did not, and the Court of Appeal saw no basis to disturb that finding.
Next, the court addressed the quantity of drugs and the plausibility of the appellant’s explanation for possessing such a large amount. The Court of Appeal accepted that the burden lay on the appellant to show why he would need to stockpile the relevant quantity if it was truly for personal consumption. The appellant’s explanations included references to the Deepavali holiday and what “Abang” had told him. The trial judge had found these explanations insufficiently cogent. The Court of Appeal endorsed that reasoning, noting a “substantial discrepancy” in the appellant’s narrative: if supply difficulties around the holiday were expected, one would anticipate that any such issues would have been resolved after the holiday. Yet the appellant was able to obtain more than usual after Deepavali, which undermined the claimed rationale for the large stockpile.
The court then considered the paraphernalia found in the appellant’s flat. The presence of multiple zip lock bags and weighing scales is often a strong indicator of preparation for distribution rather than mere consumption. The trial judge had reasoned that the appellant did not satisfactorily explain the number and nature of these items. The Court of Appeal agreed that, absent more evidence supporting the appellant’s contention that the paraphernalia was only used for occasional sales or reciprocal sharing, the natural inference was that the items were for a more sustained level of sales to others. This reasoning was consistent with the broader approach in MDA cases: while paraphernalia alone may not always be conclusive, it becomes highly probative when paired with an otherwise unpersuasive consumption narrative and a large quantity exceeding the trafficking threshold.
Finally, the Court of Appeal dealt with the appellant’s financial evidence. The trial judge had found it neutral and equivocal and did not treat it as supporting an inference of trafficking. The Court of Appeal did not disturb this assessment. However, the court’s conclusion did not depend on finances. Rather, the court found that the totality of evidence—particularly the failure to rebut the presumption through credible consumption evidence and the trafficking-associated paraphernalia—was sufficient to uphold the conviction.
What Was the Outcome?
The Court of Appeal dismissed the appeal. It held that the appellant had not provided any basis to disturb the trial judge’s findings of fact, and that those findings were amply supported by the evidence on record. In particular, the consumption defence was not established on a balance of probabilities, and the presumption of trafficking under s 17(c) of the MDA therefore remained unrebutted.
As a result, the appellant’s conviction for trafficking and the mandatory death sentence imposed at first instance were upheld. The Court of Appeal also affirmed that the alternative sentencing regime under ss 33B(1) and 33B(2) did not apply on the facts, leaving the mandatory sentence as the legal consequence.
Why Does This Case Matter?
This decision is significant for practitioners because it illustrates, in a straightforward way, the evidential burden an accused must meet to rebut the presumption of trafficking where the quantity exceeds the statutory threshold. The case reinforces that a consumption defence must be supported by credible, consistent evidence, and that the accused must prove that the entire quantity was intended for personal consumption. Where the defence is framed as “personal use” but the evidence does not credibly explain the quantity, the presumption will not be rebutted.
For defence counsel, the case underscores the importance of aligning the accused’s narrative with medical evidence and with the practical realities of supply and consumption. The court’s approach to the Deepavali explanation demonstrates that courts will test the internal logic of the accused’s account, including whether the narrative coherently explains why the accused possessed a large stockpile at the relevant time. Similarly, the court’s treatment of paraphernalia shows that even if an accused claims personal consumption, the presence of multiple weighing scales and packaging materials can substantially weaken the defence unless there is persuasive corroboration.
For prosecutors, the case confirms that the statutory presumption is robust and can be sustained by a combination of factors: lack of credible consumption evidence, implausibility of explanations for quantity, and trafficking-associated paraphernalia. The decision therefore serves as a useful reference point for how courts evaluate the consumption defence in MDA trafficking cases and how appellate courts will generally defer to trial findings of fact where the record supports them.
Legislation Referenced
- Criminal Procedure Code (Cap 68, 2012 Rev Ed), s 22 [CDN] [SSO]
- Misuse of Drugs Act (Cap 185, 2008 Rev Ed), s 5(1)(a) [CDN] [SSO]
- Misuse of Drugs Act (Cap 185, 2008 Rev Ed), s 5(2) [CDN] [SSO]
- Misuse of Drugs Act (Cap 185, 2008 Rev Ed), s 17(c) [CDN] [SSO]
- Misuse of Drugs Act (Cap 185, 2008 Rev Ed), s 33(1) [CDN] [SSO]
- Misuse of Drugs Act (Cap 185, 2008 Rev Ed), Second Schedule
- Misuse of Drugs Act (Cap 185, 2008 Rev Ed), ss 33B(1) and 33B(2) [CDN] [SSO]
Cases Cited
- [1995] SGHC 120
- [2021] SGHC 218
- [2022] SGCA 39
Source Documents
This article analyses [2022] SGCA 39 for legal research and educational purposes. It does not constitute legal advice. Readers should consult the full judgment for the Court's complete reasoning.